 | | Vol. 13.13 – 15 April, 2021 |
| |
|
|
| The therapeutic effects of umbilical cord MSC-derived extracellular vesicleson pulmonay fibrosis were evaluated using bleomycin-induced mouse models.
[Stem Cell Research & Therapy] |
|  |
|
|
| PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| Scientists generated an induced pluripotent stem cell line GZHMCi004-A derived from umbilical cord blood mononuclear cells of a fetus with heterozygous G380R mutation in FGFR3 gene.
[Stem Cell Research] |
|
|
|
| Researchers studied the underlying mechanism of extracellular vesicle‐derived microRNA‐18 in preeclampsia.
[Journal of Cellular and Molecular Medicine] |
|
|
|
| Expression of Angiotensin-Converting Enzyme 2 (ACE2) and transmembrane Serine Protease 2 (TMPRSS2) was analyzed in 24 lots of human umbilical cord-MSCs derived from Wharton’s jelly via quantitative PCR, Western Blot, immunofluorescence and flow cytometry using 24 different donors.
[Journal of Translational Medicine] |
|
|
|
| Researchers concluded that, after pre-term birth onset, a shift from immunoregulation towards inflammation takes place in cord blood cells that were reportedly representative of the fetal compartment.
[Journal of Reproductive Immunology] |
|
|
|
| Untargeted nuclear magnetic resonance metabolomics was applied in 84 umbilical cord blood and maternal blood samples obtained from 48 intrauterine growth restriction and 36 appropriate for gestational age deliveries.
[Scientific Reports] |
|
|
|
| Investigators examined the epigenetic effects induced by in utero chlordecone exposure on human male cord blood as well as in blood-derived Ke-37 cell line.
[Life Science Alliance] |
|
|
|
|
| Scientists summarize the current state of MSC-based cell therapy, focusing on the systemic safety and biodistribution of MSCs.
[Journal of Biomedical Science] |
|
|
|
|
| Sentien Biotechnologies, Inc. announced it has completed enrollment of the first cohort in its Phase I/II study of SBI-101 for the treatment of severe COVID-19. SBI-101 is being evaluated in COVID-19 patients suffering from both acute respiratory distress syndrome and acute kidney injur requiring renal replacement therapy.
[Sentien Biotechnologies, Inc.] |
|
|
|
| Celularity, Inc. announced FDA has granted Orphan Drug Designation to the company’s non-genetically modified cryopreserved human placental hematopoietic stem cell-derived natural killer cell therapy, CYNK-001, for the treatment of patients with malignant gliomas.
[Celularity, Inc.] |
|
|
|
| Therapeutic Solutions International, Inc., announced filing of a patent with new data covering a cord blood based intranasal product demonstrated to reduce adverse mental effects associated with opioid addiction.
[Therapeutic Solutions International, Inc. (PR Newswire)] |
|
|
|
|
| September 22 – 24, 2021
Virtual |
|
|
|
|
|
| | Rutgers University – New Brunswick, New Jersey, United States |
|
|
|
| | University of Chicago – Chicago, Illinois, United States |
|
|
|
| | American Association for Cancer Research – Boston, Massachusetts, United States |
|
|
|
| | Moores Cancer Center – La Jolla, California, United States |
|
|
|
| | University of Washington – Seattle, Washington, United States |
|
|
|
|
Cancer Stem Cell News
Cell Therapy News
Dermal Cell News
Endothelial Cell News
ESC & iPSC News
Extracellular Matrix News
Hematopoiesis News
Hepatic Cell News
Human Immunology News
Immune Regulation News
Intestinal Cell News
Mammary Cell News
Mesenchymal Cell News
Muscle Cell News
Neural Cell News
Organoid News
Pancreatic Cell News
Prostate Cell News
Pulmonary Cell News
